Sweden
· Delayed Price · Currency is SEK Humana AB Statistics
Total Valuation
Humana AB has a market cap or net worth of SEK 1.82 billion. The enterprise value is 6.39 billion.
| Market Cap | 1.82B |
| Enterprise Value | 6.39B |
Important Dates
The next estimated earnings date is Friday, July 18, 2025.
| Earnings Date | Jul 18, 2025 |
| Ex-Dividend Date | May 7, 2025 |
Share Statistics
Humana AB has 49.84 million shares outstanding. The number of shares has increased by 6.77% in one year.
| Current Share Class | 49.84M |
| Shares Outstanding | 49.84M |
| Shares Change (YoY) | +6.77% |
| Shares Change (QoQ) | -0.80% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 26.79% |
| Float | 26.55M |
Valuation Ratios
The trailing PE ratio is 9.49 and the forward PE ratio is 8.03.
| PE Ratio | 9.49 |
| Forward PE | 8.03 |
| PS Ratio | 0.18 |
| PB Ratio | 0.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.03 |
| P/OCF Ratio | 2.02 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.75, with an EV/FCF ratio of 10.59.
| EV / Earnings | 32.42 |
| EV / Sales | 0.61 |
| EV / EBITDA | 5.75 |
| EV / EBIT | 12.42 |
| EV / FCF | 10.59 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.55.
| Current Ratio | 0.80 |
| Quick Ratio | 0.75 |
| Debt / Equity | 1.55 |
| Debt / EBITDA | 4.58 |
| Debt / FCF | 8.43 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is 6.32% and return on invested capital (ROIC) is 3.82%.
| Return on Equity (ROE) | 6.32% |
| Return on Assets (ROA) | 3.15% |
| Return on Invested Capital (ROIC) | 3.82% |
| Return on Capital Employed (ROCE) | 6.61% |
| Revenue Per Employee | 610,701 |
| Profits Per Employee | 11,545 |
| Employee Count | 13,386 |
| Asset Turnover | 1.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana AB has paid 54.00 million in taxes.
| Income Tax | 54.00M |
| Effective Tax Rate | 21.43% |
Stock Price Statistics
The stock price has increased by +10.10% in the last 52 weeks. The beta is 0.29, so Humana AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +10.10% |
| 50-Day Moving Average | 38.35 |
| 200-Day Moving Average | 38.37 |
| Relative Strength Index (RSI) | 49.10 |
| Average Volume (20 Days) | 104,672 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Humana AB had revenue of SEK 10.42 billion and earned 197.00 million in profits. Earnings per share was 3.86.
| Revenue | 10.42B |
| Gross Profit | 2.28B |
| Operating Income | 514.00M |
| Pretax Income | 252.00M |
| Net Income | 197.00M |
| EBITDA | 595.00M |
| EBIT | 514.00M |
| Earnings Per Share (EPS) | 3.86 |
Balance Sheet
The company has 658.00 million in cash and 5.08 billion in debt, giving a net cash position of -4.43 billion or -88.78 per share.
| Cash & Cash Equivalents | 658.00M |
| Total Debt | 5.08B |
| Net Cash | -4.43B |
| Net Cash Per Share | -88.78 |
| Equity (Book Value) | 3.29B |
| Book Value Per Share | 62.26 |
| Working Capital | -477.00M |
Cash Flow
In the last 12 months, operating cash flow was 901.00 million and capital expenditures -298.00 million, giving a free cash flow of 603.00 million.
| Operating Cash Flow | 901.00M |
| Capital Expenditures | -298.00M |
| Free Cash Flow | 603.00M |
| FCF Per Share | 12.10 |
Margins
Gross margin is 21.87%, with operating and profit margins of 4.93% and 1.89%.
| Gross Margin | 21.87% |
| Operating Margin | 4.93% |
| Pretax Margin | 2.42% |
| Profit Margin | 1.89% |
| EBITDA Margin | 5.71% |
| EBIT Margin | 4.93% |
| FCF Margin | 5.79% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.70%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.70% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -6.77% |
| Shareholder Yield | -4.02% |
| Earnings Yield | 10.80% |
| FCF Yield | 33.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Humana AB has an Altman Z-Score of 1.55 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.55 |
| Piotroski F-Score | 6 |